Announcements Trials
Browse Landscape

Phase

Phase 2 6Phase 3 3Phase NA 2Phase 4 1Phase 2/3 1

Status

Completed 13Recruiting 11Active not recruiting 9Unknown 3Terminated 1Not yet recruiting 1

Sponsor Class

OTHER 2NIH 1

Study Type

Interventional 3

Sponsor

Cancer Type

Genitourinary 3

Conditions

Prostatic Neoplasms 3

Interventions

Cisplatin 130Radiotherapy 94Carboplatin 85Paclitaxel 78Fluorouracil 78Cyclophosphamide 77Gemcitabine 72Capecitabine 66Docetaxel 65Doxorubicin 60Oxaliplatin 59Etoposide 57Leucovorin 49Vincristine 47Chemotherapy, Adjuvant 42Cytarabine 38Dexamethasone 35Drug Therapy 33Bevacizumab 30Epirubicin 29Neoadjuvant Therapy 28Pemetrexed 27Tamoxifen 25Prednisone 24Irinotecan 24Rituximab 21Methotrexate 21Radiotherapy, Intensity-Modulated 19apatinib 18Vinorelbine 18

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 3 × Unknown × Androgen Antagonists × Clear all
NCT03119857 2021-08-18

Early Rising PSA Endocrine Treatment Versus Chemo-endocrine Therapy- SPCG14

Göteborg University

Phase 3 Unknown
349 enrolled
Genitourinary

Prostatic Neoplasms

NCT01978873 2016-05-04

SensiCab

Örebro University, Sweden

Phase 3 Unknown
400 enrolled
Genitourinary

Prostatic Neoplasms

NCT00110162 2013-08-07

Androgen Deprivation Therapy in Treating Patients With Prostate Cancer

National Cancer Institute (NCI)

Phase 3 Unknown
2,000 enrolled
Genitourinary

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡